期刊文献+

hTERT蛋白在胃腺癌组织中定量表达的研究

Expression of human telomerase reverse transcriptase in gastric adenocarcinoma
下载PDF
导出
摘要 目的探讨hTERT蛋白在胃腺癌组织中表达情况及其与胃癌进展的关系。方法对68例胃腺癌和10例正常组织采用流式细胞术定量检测hTERT蛋白的表达。结果hTERT蛋白流式细胞术测定在进展期胃癌、早期胃癌和正常胃黏膜荧光指数FI值分别为1.92±0.17、1.60±0.18和0.98±0.15,进展期胃癌hTERT含量高于早期胃癌(P<0.01)、早期胃癌高于正常胃黏膜(P<0.01);中、低分化腺癌hTERT蛋白FI值分别为1.89±0.20和1.92±0.19显著高于高分化腺癌1.71±0.19(P<0.01);有淋巴结转移者高于无淋巴结转移者(P<0.05);T1-T2级胃癌TERT蛋白FI值高于T3-T4级胃癌(P<0.05)。结论hTERT高表达与胃腺癌进展相关,可作为胃癌进展的生物学标志之一。 Objectives To discuss the expression level of hTERT protein in human gastric adenocarcinoma tissue and its relationship between hTERT protein and progression of gastric adenocarcinoma. Methods Quantitative expression of hTERTprotein was explored with flow cytometry method in 68 cases of gastric adenocarcinoma and 10 cases of normal gastric mucosa as control. Results FI value of hTERT protein in advanced gastric carcinoma, early gastric carcinoma and normal mucosa were 1.92 ± 0.17,1.60±0.18 and 0.98 ±0.15 respectively with folw cytometry. FI value in advanced gastric carcinoma was markedly higher than that in early gastric carcinoma( P 〈0. 01) ,and FI value early gastric carcinoma was also increased than that in normal mucosa( P 〈 0. 01 ). FI value of hTERT in moderately differentiatied gastric adenocarcinom and poorly differentiated gastric adenocarcinoma were 1.89±0.20 and 1.92 ±0.19,which was distinctly higher than that in normal mucosa 1.71 ± 0.19 (P 〈 0. 01 ). FI value in lymph node metastasized carcinoma was ascended compared with that of lymph node negative carcinoma. FI value of hTERT of T1 - T1 grade was higher than that of T3 - T4 grade in gastric carcinoma ( P 〈 0. 05 ). Conclusion There is a correlation between overpressed hTERT protein and gastric adenocarcinoma,hTERT protein maybe a biomarker for gastric progression.
出处 《河北职工医学院学报》 2007年第1期7-9,共3页 Journal of Hebei Medical College for Continuing Education
关键词 HTERT 胃腺癌 流式细胞术 human telomerase reverse transcriptase gastric adenocarcinoma flow cytometry
  • 相关文献

参考文献13

  • 1GongYS,Woodring WE,Shay JW.Human telomerase and its regulation[J].Microbiol Mol Biol Rev,2002,66(3):407-425.
  • 2Natarajan S,Chen Z,Wancewicz EV,et al.Telomerase reverse transcriptase (hTERT)mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase acivity[J].Oligonucleotides,2004,14 (4):263-273.
  • 3Bowles L,Bialkowska-Hoberanska H,BukalaB,et al.A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer[J].Can J Urol,2004,11 (6):2438 -2444.
  • 4Tominaga T,Kashimura H,Suzuki K,et al.Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues[J].J Gastroenterol,2002,37(6):418 -427.
  • 5中国抗癌协会.新编常见恶性肿瘤诊治规范胃癌分册[M].北京:北京医科大学中国协和医科大学联合出版社,1995.5-7.
  • 6Morkve O,Leaerum OD.Flow cytometry measurement of p21,p53 protein expression and DNA content in paraffin embed tissues from bronchial carcinoma[J].Cytometry,1991,12:438 -444.
  • 7Stewart SA,Hahn WC,OrConnor BF,et al.Telomerase contributes to tumorigenesis by a telomere length-independent mechanism[J].Proc Natl Acad Sci USA,2002,99(20):12606-12611.
  • 8Natarajan S,Chen Z,Wancewicz EV,et al.Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity[J].Oligonucleotides,2004,14 (4):263-273.
  • 9Yan P,Benhattar J,Seelentag W,at al.Immunohistochemical localization of hTERT protein in human tissues[J].Histochem Cell Biol,2004,121 (5):391-397.
  • 10Lantuejoul S,Soria JC,Moro-Sibilot D,et al.Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours[J].Br J Cancer,2004,90 (6):1222-1229.

二级参考文献11

  • 1Jong HS, Park YI, Kim S, et al. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis[J]. Cancer, 1999, 86: 559-565
  • 2Yasui W, Tahara E, Tahara H, et al. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach[J]. Jpn J Cancer Res, 1999, 90: 589-595
  • 3Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues[J]. Int J Cancer, 1999, 80:60-63
  • 4Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells[J]. Science, 1998, 279: 349-352
  • 5Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer[J]. Caner Res, 1998, 58: 1558-1561
  • 6Yang SM, Zhang B, Wang JM, et al. Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application[J]. Hybridoma,2001, 20:249-255
  • 7Kanaya T, Kyo S, Takakura M, et al. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma[J]. Int J Cancer, 1998,78:539-543
  • 8Yasui W, Tahara H, Tahara E, et al. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas[J]. Jpn J Cancer Res, 1998,89(11): 1099-1103
  • 9张方信,国外医学.生理、病理科学与临床分册,1997年,1期,46页
  • 10杨仕明,房殿春,罗元辉,鲁荣,刘为纹.胃癌及癌前组织中端粒酶活性的检测及其临床意义[J].中华医学杂志,1998,78(3):207-209. 被引量:52

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部